Pemphigus foliaceus: an adverse reaction to lisinopril

Lisinopril is an angiotensin converting enzyme inhibitor used in the treatment of cardiovascular disease. We report a case of pemphigus foliaceus in a 66‐year‐old male treated with lisinopril for hypertension and a previous myocardial infarction. The drug‐induced variant of pemphigus is caused by a wide variety of drugs and is most frequently associated with captopril and penicillamine. It has not previously been reported in this commonly used drug.

[1]  Stephen Lee,et al.  Drug‐related pemphigus and angiotensin converting enzyme inhibitors , 2000, The Australasian journal of dermatology.

[2]  S. Brenner,et al.  Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. , 1997, Journal of the American Academy of Dermatology.

[3]  L. Dubertret,et al.  Ramipril‐induced superficial pemphigus , 1996, The British journal of dermatology.

[4]  S. Muller,et al.  Angiotensin-converting enzyme inhibitor-induced pemphigus: three case reports and literature review. , 1994, Mayo Clinic proceedings.

[5]  R. Wolf,et al.  An active amide group in the molecule of drugs that induce pemphigus: a casual or causal relationship? , 1994, Dermatology.

[6]  V. Ruocco,et al.  ENALAPRIL: A POWERFUL IN VITRO NON‐THIOL ACANTHOLYTIC AGENT , 1992, International journal of dermatology.

[7]  A. Smith,et al.  Rheumatoid arthritis: an association with pemphigus foliaceous. , 1992, Acta dermato-venereologica.

[8]  A. Woscoff,et al.  Progressive systemic sclerosis and pemphigus vulgaris. , 1989, Journal of the American Academy of Dermatology.